SIA
TMO icon

SGL Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

SGL Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-674
Closed -$305K – 141
2026
Q1 		$305K Sell
674
-32
-5% -$17.4K 0.11% 111
2025
Q4 		$383K Buy
+706
New +$399K 0.15% 104
2025
Q1 		– Sell
-403
Closed -$217K – 120
2024
Q4 		$217K Buy
+403
New +$222K 0.11% 112

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SGL Investment Advisors's TMO Position: Q2 2026 in Review

SGL Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 674 shares — an estimated $305K sold.

SGL Investment Advisors first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $383K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • SGL Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • SGL Investment Advisors sold 674 Thermo Fisher Scientific shares in Q2 2026, an estimated $305K.
  • SGL Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
  • SGL Investment Advisors's Thermo Fisher Scientific position peaked at $383K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.